Skip to main content
Back
Watch Compare

MapLight Therapeutics, Inc.

Data quality: 83%
MPLT
NASDAQ Manufacturing Chemicals
$30.64
▲ $2.13 (7.47%)
6 months return
—
Momentum
Neutral
ROE
-35.16%

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-35.16%
Above sector avg (-54.68%)
ROIC-28.83%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio13.22
Interest CoverageN/A

Valuation

P/E Ratio
-8.10 TTM
-7.20 NTM
Below sector avg (-1.49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -138.61 M

Price History

Financial Trends

Analyst Price Target

6 analysts
Buy
+6.6%
upside to target
Current
$30.64
Consensus Target
$32.67
$28.00
Low
$37.00
High
Forecast
Forward P/E
-7.20
Forward EPS
-$3.74
Est. Revenue
0.0

Earnings Surprises

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -$1.17 · Rev Est: 0.0
Q32025 Q42025 Q1 '26 Q2 '26
Reported -$37.18 -$2.47 — —
Estimate -$1.73 -$0.83 -$1.17 -$1.19
Surprise -2055.36% -197.59% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -35.16% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -161.15 M
ROE -35.16% ROA -33.61%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -138.61 M
ROIC -28.83% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 13.22
Debt / Equity N/A Current Ratio 13.22
Interest Coverage N/A Asset Turnover N/A
Working Capital 226.74 M Tangible Book Value -274.18 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -8.10 · EV/EBITDA: N/A
P/E Ratio -8.10 Forward P/E -7.20
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10.62%
Market Cap 1.31 B Enterprise Value 1.24 B

Per Share

EPS: -18.56 · FCF/Share: -3.05
EPS (Diluted TTM) -18.56 Revenue / Share N/A
FCF / Share -3.05 OCF / Share -3.04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 86.01% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 86.01%
SBC-Adj. FCF -174.62 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -161.15 M
EPS (Diluted) -18.56
Gross Profit —
Operating Income -169.08 M
EBITDA —
R&D Expenses 138.35 M
SG&A Expenses —
D&A —
Interest Expense —
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 479.51 M
Total Liabilities 21.14 M
Shareholders' Equity 458.37 M
Total Debt —
Cash & Equivalents 46.73 M
Current Assets 324.67 M
Current Liabilities 16.23 M

Peer Comparison

vs Manufacturing sector median (1605 peers)
Metric Stock Sector Median
P/E -8.1 -1.5
P/B — 1.6
ROE % -35.2 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3

ETFs Holding This Stock
IRSIX IRSIX
0.01% weight
IIRSX IIRSX
0.01% weight
IRCIX IRCIX
0.01% weight
VVICX VVICX
0.01% weight